Angiotensin Converting Enzyme 2 News and Research

RSS
Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Multi-omics identify COVID-19 severity predictors and prothrombotic signatures in patients with end-stage kidney disease

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Precision cut slice lung model to study early host viral pathogenesis of SARS-CoV-2 infection

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Studying immunomodulatory effects of microbiota helps design prophylactic and therapeutic interventions against COVID-19

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Study reveals Omicron sub-lineages BA.4 and BA.5 escape neutralizing antibodies elicited in response to BA.1 infection

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Features of SARS-CoV-2 Omicron BA.2 sublineage spike protein

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

Long COVID is characterized SARS-CoV-2 antigen persistence in the gut mucosa

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Antibody cocktail shows synergetic effects against SARS-CoV-2 Omicron in vitro and in vivo

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Study reports an orally available SARS-CoV-2 Mpro inhibitor with potent in vivo antiviral activity

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Study finds curcumin is a potential therapeutic agent against the Omicron variant of SARS-CoV-2

Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

Identification of a SARS-CoV-2 neutralizing human monoclonal antibody with a remarkable broad-spectrum neutralization and protection efficacy

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

Evidence of accelerated epigenetic age in SARS-CoV-2-positive patients

Bebtelovimab potently neutralizes all SARS-CoV-2 variants of concern

Bebtelovimab potently neutralizes all SARS-CoV-2 variants of concern

The preclinical potential of a herb used in traditional Chinese medicine for the treatment of COVID-19

The preclinical potential of a herb used in traditional Chinese medicine for the treatment of COVID-19

Superior T-cell immunity in COVID vaccinated

Superior T-cell immunity in COVID vaccinated

Antibodies against the original strain of SARS-CoV-2 may not work as well with omicron

Antibodies against the original strain of SARS-CoV-2 may not work as well with omicron

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

The response of four SARS-CoV-2 spike variants to linoleic acid removal

The response of four SARS-CoV-2 spike variants to linoleic acid removal

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation